PROGRESSION OF ESSENTIAL THROMBOCYTHEMIA TO BLASTIC CRISIS VIA IDIOPATHIC MYELOFIBROSIS

被引：30

作者：

EMILIA, G

SACCHI, S

TEMPERANI, P

LONGO, R

VECCHI, A

机构：

[1] Second Medical Clinic, University of Modena

来源：

LEUKEMIA & LYMPHOMA | 1993年 / 9卷 / 4-5期

关键词：

ESSENTIAL THROMBOCYTHEMIA; IDIOPATHIC MYELOFIBROSIS; LEUKEMIA;

D O I：

10.3109/10428199309148545

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We report a 61-year-old man with essential thrombocythemia (ET) whose clinical course was followed for 12 years. The ET evolved into true idiopathic myelofibrosis (IM) 6 years after the initial diagnosis and progressed to myeloid blastic transformation 6 years later. The cytogenetic analysis showed a normal karyotype during the ET phase but subsequent analysis revealed an abnormal karyotype during the IM phase which evolved clonally at blastic crisis with constant involvement of chromosome 13q and chromosome 7. The close monitoring of essential events, using clinical, morphologic, immunologic and cytogenetic parameters, allowed us to carefully identify the transition from one chronic myeloproliferative disease (MPD) to another. This is only the second case reported showing a clinical evolution of this nature. The clinical and biological aspects of the disease are briefly discussed.

引用

页码：423 / 426

页数：4

共 22 条

[1] Adam J.A., Barrett A.J., Beard J., McCarthy D.M., Primary polycythaemia, essential thrombocythaemia and myelofibrosis. Three facets of a single disease process?, Acta Haemal, 79, pp. 33-37, (1988)
[2] Bellucci S., Janvier M., Tobelem G., Flandrin G., Charpak Y., Berger R., Boiron M., Essential thrombocythemias. Clinical evolutionary and biological data, Cancer, 58, pp. 2440-2447, (1986)
[3] Borgstrom G.H., Kuuntila S., Ruutu T., Pakkala A., Lahtinen R., de la Chapelle A., Abnormalities of chromosome 13 in myelofibrosis, Scand. J. Haematol, 33, pp. 15-21, (1984)
[4] Emilia G., Torelli G., Sacchi S., Donelli A., Chromosomal abnormalities in essential thrombocythemia, Cancer Genet Cytogenet, 18, pp. 91-93, (1985)
[5] Fenaux P., Simon M., Caulier M.T., Lai J.L., Goudemand J., Bauters F., Clinical course of essential thrombocythemia in 147 cases, Cancer, 66, pp. 549-556, (1990)
[6] Fialkow P.J., Faguet G.B., Jacobson R.J., Waidya K., Murphy S., Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell, Blood, 58, pp. 916-919, (1981)
[7] Frei-Lahr D., Barton J.C., Hoffman R., Burkett L.L., Prchal J.T., Blastic transformation of essential thrombocythemia: dual expression of myelomonoblastic-megacaryoblastic phenotypes, Blood, 63, pp. 866-872, (1984)
[8] Geller S.A., Shapiro E., Acute leukemia as a natural sequel to primary thrombocythemia, Am. J. Clin. Pathol, 77, pp. 353-356, (1982)
[9] Hehlmann R., Jahn M., Baumann B., Kopcke W., Essential thrombocythemia. Clinical characteristics and course of 61 cases, Cancer, 61, pp. 2487-2496, (1988)
[10] Janssen J.W.G., Anger B.R., Drexler H.G., Bartram C.R., Heimpel H., Essential thrombocythemia in two sisters originating from different stem cell levels, Blood, 75, pp. 1633-1636, (1990)

← 1 2 3 →